Literature DB >> 12891002

Regulation of matrix metalloproteinase (matrixin) genes in blood vessels: a multi-step recruitment model for pathological remodelling.

Alex J Chase1, Andrew C Newby.   

Abstract

Matrix metalloproteinases (MMPs; matrixins) are a family of structurally related enzymes that collectively promote turnover of all components of the extracellular matrix. Matrix turnover is required for vascular repair, but, if excessive, leads to pathologies that include aneurysm formation and atherosclerotic plaque instability. We review the positive and negative regulation of metalloproteinase gene induction. We propose that multiple steps of gene induction recruit a wider spectrum of MMPs, which may ultimately lead to a transition from matrix turnover to matrix destruction. Studying the detailed mechanisms involved may suggest possibilities for intervening selectively against pathological MMP induction. Copyright 2003 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12891002     DOI: 10.1159/000072697

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  21 in total

Review 1.  Extra-cellular matrix in vascular networks.

Authors:  George Bou-Gharios; Markella Ponticos; Vineeth Rajkumar; David Abraham
Journal:  Cell Prolif       Date:  2004-06       Impact factor: 6.831

2.  Vein tissue expression of matrix metalloproteinase as biomarker for hemodialysis arteriovenous fistula maturation.

Authors:  Eugene S Lee; Qiang Shen; Robert L Pitts; Mingzhang Guo; Mack H Wu; Sarah Y Yuan
Journal:  Vasc Endovascular Surg       Date:  2010-08-18       Impact factor: 1.089

3.  Matrix metalloproteinases and their regulators are cardiovascular therapeutic targets.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2004-12       Impact factor: 4.599

Review 4.  Matrix metalloproteinases and the regulation of tissue remodelling.

Authors:  Andrea Page-McCaw; Andrew J Ewald; Zena Werb
Journal:  Nat Rev Mol Cell Biol       Date:  2007-03       Impact factor: 94.444

Review 5.  Progress in matrix metalloproteinase research.

Authors:  Gillian Murphy; Hideaki Nagase
Journal:  Mol Aspects Med       Date:  2008-05-24

6.  Effects of statins on matrix metalloproteinases and their endogenous inhibitors in human endothelial cells.

Authors:  Tatiane C Izidoro-Toledo; Danielle A Guimaraes; Vanessa A Belo; Raquel F Gerlach; Jose Eduardo Tanus-Santos
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-03-30       Impact factor: 3.000

7.  Differential Gene Expression in Coiled versus Flow-Diverter-Treated Aneurysms: RNA Sequencing Analysis in a Rabbit Aneurysm Model.

Authors:  A Rouchaud; C Johnson; E Thielen; D Schroeder; Y-H Ding; D Dai; W Brinjikji; J Cebral; D F Kallmes; R Kadirvel
Journal:  AJNR Am J Neuroradiol       Date:  2015-12-31       Impact factor: 3.825

8.  Serum metalloproteinases MMP-2, MMP-9, and metalloproteinase tissue inhibitors in patients are associated with arteriovenous fistula maturation.

Authors:  Eugene S Lee; Qiang Shen; Robert L Pitts; Mingzhang Guo; Mack H Wu; Sue C Sun; Sarah Y Yuan
Journal:  J Vasc Surg       Date:  2011-05-28       Impact factor: 4.268

Review 9.  Vein graft failure.

Authors:  Christopher D Owens; Warren J Gasper; Amreen S Rahman; Michael S Conte
Journal:  J Vasc Surg       Date:  2013-10-03       Impact factor: 4.268

10.  Established neointimal hyperplasia in vein grafts expands via TGF-beta-mediated progressive fibrosis.

Authors:  Zhihua Jiang; Ming Tao; Kerri A Omalley; Danlu Wang; C Keith Ozaki; Scott A Berceli
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-07-17       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.